Charles Schwab’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$582M Sell
2,183,306
-8,757
-0.4% -$2.42M 0.09% 185
2025
Q4
$603M Buy
2,192,063
+84,575
+4% +$23.7M 0.09% 178
2025
Q3
$607M Buy
2,107,488
+54,576
+3% +$16.1M 0.1% 179
2025
Q2
$679M Buy
2,052,912
+15,014
+0.7% +$4.84M 0.12% 152
2025
Q1
$670M Buy
2,037,898
+60,140
+3% +$18.1M 0.13% 146
2024
Q4
$546M Buy
1,977,758
+64,138
+3% +$20.4M 0.1% 169
2024
Q3
$663M Sell
1,913,620
-147,009
-7% -$50.6M 0.13% 138
2024
Q2
$681M Buy
2,060,629
+17,087
+0.8% +$5.89M 0.13% 139
2024
Q1
$742M Buy
2,043,542
+65,077
+3% +$21.4M 0.17% 109
2023
Q4
$592M Buy
1,978,465
+53,414
+3% +$15.6M 0.15% 117
2023
Q3
$551M Buy
1,925,051
+30,352
+2% +$8.66M 0.16% 112
2023
Q2
$532M Buy
1,894,699
+20,324
+1% +$5.29M 0.15% 116
2023
Q1
$479M Buy
1,874,375
+3,575
+0.2% +$1.04M 0.15% 125
2022
Q4
$620M Buy
1,870,800
+67,677
+4% +$21.4M 0.2% 102
2022
Q3
$500M Sell
1,803,123
-28,861
-2% -$8.12M 0.18% 108
2022
Q2
$483M Buy
1,831,984
+23,849
+1% +$6.15M 0.17% 110
2022
Q1
$433M Buy
1,808,135
+28,643
+2% +$6.71M 0.13% 138
2021
Q4
$409M Buy
1,779,492
+30,257
+2% +$6.43M 0.12% 151
2021
Q3
$350M Buy
1,749,235
+28,417
+2% +$6.18M 0.11% 158
2021
Q2
$408M Sell
1,720,818
-17,912
-1% -$4.47M 0.14% 135
2021
Q1
$420M Sell
1,738,730
-234,588
-12% -$52.3M 0.15% 119
2020
Q4
$411M Sell
1,973,318
-2,689
-0.1% -$527K 0.16% 120
2020
Q3
$335M Sell
1,976,007
-7,127
-0.4% -$1.25M 0.15% 128
2020
Q2
$372M Buy
1,983,134
+31,467
+2% +$5.97M 0.18% 106
2020
Q1
$346M Buy
1,951,667
+33,375
+2% +$6.47M 0.2% 100
2019
Q4
$392M Sell
1,918,292
-14,659
-0.8% -$2.69M 0.21% 87
2019
Q3
$293M Buy
1,932,951
+32,317
+2% +$5.26M 0.17% 109
2019
Q2
$299M Buy
1,900,634
+42,597
+2% +$6.68M 0.18% 100
2019
Q1
$299M Buy
1,858,037
+128,783
+7% +$23.5M 0.19% 96
2018
Q4
$328M Buy
1,729,254
+757,322
+78% +$158M 0.25% 71
2018
Q3
$202M Buy
971,932
+24,352
+3% +$4.51M 0.13% 141
2018
Q2
$161M Buy
947,580
+21,306
+2% +$3.69M 0.12% 163
2018
Q1
$155M Buy
926,274
+22,131
+2% +$4.3M 0.12% 160
2017
Q4
$184M Buy
904,143
+29,553
+3% +$5.88M 0.15% 135
2017
Q3
$163M Buy
874,590
+7,407
+0.9% +$1.32M 0.14% 137
2017
Q2
$145M Buy
867,183
+26,244
+3% +$4.22M 0.14% 144
2017
Q1
$123M Buy
840,939
+78,394
+10% +$11.6M 0.12% 154
2016
Q4
$102M Buy
762,545
+40,174
+6% +$5.26M 0.11% 171
2016
Q3
$94.1M Buy
722,371
+9,786
+1% +$1.28M 0.11% 170
2016
Q2
$91.2M Buy
712,585
+13,913
+2% +$1.84M 0.11% 168
2016
Q1
$95.9M Buy
698,672
+18,974
+3% +$2.61M 0.13% 151
2015
Q4
$99.5M Buy
679,698
+21,101
+3% +$2.9M 0.13% 147
2015
Q3
$88.9M Buy
658,597
+2,069
+0.3% +$300K 0.13% 148
2015
Q2
$106M Buy
656,528
+8,531
+1% +$1.18M 0.15% 134
2015
Q1
$83.9M Buy
647,997
+26,019
+4% +$3.02M 0.12% 172
2014
Q4
$64M Buy
621,978
+16,931
+3% +$1.67M 0.1% 209
2014
Q3
$54.9M Buy
605,047
+22,396
+4% +$2.09M 0.09% 220
2014
Q2
$53.6M Sell
582,651
-275,172
-32% -$23.6M 0.09% 217
2014
Q1
$71.8M Sell
857,823
-362,692
-30% -$29.9M 0.13% 158
2013
Q4
$107M Sell
1,220,515
-491,234
-29% -$40.2M 0.2% 103
2013
Q3
$134M Sell
1,711,749
-5,411
-0.3% -$423K 0.27% 74
2013
Q2
$125M Buy
+1,717,160
New +$116M 0.28% 69

Other funds holding CI

Charles Schwab's CI Position: Q1 2026 in Review

Charles Schwab reduced its Cigna (CI) stake by 0.4% in Q1 2026, selling an estimated $2.42M and leaving 2,183,306 shares worth $582M. The position accounts for 0.09% of the portfolio, ranked #185.

Charles Schwab first reported a position in CI in Q2 2013 and has held it in 52 quarters since. The position peaked at $742M in Q1 2024. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • Charles Schwab held 2,183,306 shares of Cigna worth $582M as of Q1 2026.
  • Charles Schwab sold 8,757 Cigna shares in Q1 2026, an estimated $2.42M.
  • Cigna made up 0.09% of Charles Schwab's portfolio in Q1 2026, its #185 holding.
  • Charles Schwab first reported a position in Cigna in Q2 2013 and has held it in 52 quarters since.
  • Charles Schwab's Cigna position peaked at $742M in Q1 2024.
  • 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.